doi: 10.1161/CIRCULATIONAHA.106.629154
(Circulation. 2006;113:2569-2571.)
© 2006 American Heart Association, Inc.
Editorial |
Optimal Management Strategies for Patients With Complex Congenital Heart Disease
From the National Heart, Lung, and Blood Institute, Bethesda, Md.
Correspondence to Rae-Ellen W. Kavey, MD, MPH, National Heart, Lung, and Blood Institute, Bldg 31, Suite 4A10, Bethesda, MD 20892. E-mail kaveyr{at}nhlbi.nih.gov
Key Words: Editorials • heart defects, congenital • tetralogy of Fallot
The combination of critical pulmonary outflow obstruction with a large ventricular septal defect is symbolized by the diagnosis of tetralogy of Fallot, the most common form of cyanotic congenital heart disease. In many ways, the history of management for patients with tetralogy is representative of the evolution of management for all children with complex congenital cardiac diagnoses. Tetralogy was the first complex lesion addressed surgically with the palliative Blalock-Taussig shunt in 1945 and the first repaired completely with patients’ mothers serving as the bypass machine in 1954.1,2 The introduction of valved conduits in 1964 allowed repair of lesions not previously considered amenable to correction.3 The next 3 decades were marked by improved survival at open heart repair, recognition of the progressive deterioration of valved conduits necessitating early and repeated reoperation, and a progressive decrease in the age of primary repair to now the first few months of life.4,5 In the late 1970s, reports of arrhythmia and late sudden death among tetralogy survivors led to evaluation of tetralogy cohorts with residual right ventricular (RV) volume and/or pressure overload identified as predictors of late complications.6,7 Recognition of this problem heightened appreciation of the importance of arrhythmias in postoperative congenital heart disease patients and identified the need for informed long-term care and attention to residua of earlier procedures for all patients with congenital heart disease.8 Finally, the last 20 years have witnessed the dramatic rise in interventional procedures to address both correction of simple lesions and palliation/management of complex diagnoses.9
Article p 2598
The remarkable progress in care of children with tetralogy exemplifies the collaboration between pediatric cardiologists and congenital cardiac surgeons, the development of new techniques to address problems as they emerge, and the continuous evolution of management that have characterized care of all patients with congenital heart defects in the last 60 years.10 Despite the remarkable progress made, tetralogy also symbolizes the difficulty of critically evaluating questions in patient management when the number of patients in any one center is relatively small and when patient management continues to evolve. Although publications on congenital heart disease are numerous, most are retrospective case series with few prospective and/or randomized approaches to evaluating management questions.11
The report by Peng et al12 in this issue of Circulation encompasses all these issues. The article reports the results in 221 patients who underwent placement of 242 balloon-expandable bare metal stents to address obstructed RV-pulmonary artery (PA) conduits, the majority in patients with complex forms of tetralogy of Fallot. This is the largest reported series of stent implantation to address conduit obstruction and confirms earlier reports in smaller numbers of patients that the technique can be applied successfully in this setting.13,14 Results immediately after stent placement indicate a significant decline in RV pressure, and the authors report a delay in the need for conduit replacement surgery averaging 3.9 years in children >5 years and 2.7 years overall. There were no deaths, and procedural morbidity was minimal. No systematic change in RV function was demonstrated. At catheterization, a mean of 2.2 years after the initial stent procedure, mean RV pressures had returned to preprocedural levels. An unexpected finding was the presence of significant stent fractures in 43% of those evaluated fluoroscopically; in most cases, there was major disruption of the stent integrity. Fractures were associated with compression of the stent and substernal location and were visible only with dynamic imaging; there were no identified hemodynamic consequences. The authors conclude that conduit stenting effectively addresses RV-PA obstruction and prolongs conduit lifespan.
Peng and colleagues12 are to be commended for extending the pediatric cardiology/congenital cardiac surgery tradition of developing innovative ways to address the problems associated with management of congenital lesions and the complications of previous interventions. Any alternative to a standard therapy must demonstrate a favorable balance between risk and benefit. Unfortunately, in this retrospective series, uniform evaluation of the results of stenting was not performed; thus, significant questions remain about applying the technique in this setting. Cardiac catheterizations in 57% of patients demonstrated that RV pressures had returned to preprocedural levels at a mean of 2.2 years after stent placement. Presumably, patients whose clinical or echocardiographic findings suggested increasing obstruction are those referred for repeated catheterization, so these findings may not be generalizable to the entire group, but it is possible that stenting offers only a very temporary decrease in RV outflow obstruction. Complete results of postprocedural echocardiograms are not reported; they would have been useful for evaluating the duration of the response to stenting and the impact of pulmonary insufficiency, a universal sequela of stent placement, on RV size and function. Stent fractures were discovered incidentally at catheterization or surgery; when did they develop and what will be their clinical consequences? How did the presence of the stent impact subsequent RV outflow tract surgery, something that occurred in 70% of the patients at a mean of 2.7 years after stent placement? With no standard protocol for serial evaluation of conduit gradients, RV size and function, and stent integrity, the ultimate benefit of a temporary decrease in RV pressure, especially when accompanied by the development or progression of pulmonary insufficiency and by the risk of stent fractures, is unclear.
A technical advance like the one described here represents both an option for management of the patient with RV-PA conduit stenosis and an opportunity to reevaluate the overall approach to care in this group of patients. All currently available conduit valves deteriorate, and the smaller the conduit at original repair, the earlier progressively more abnormal hemodynamics will develop.15 The reported mortality rate at repeated conduit surgery is 1.7% to 4.9%, and morbidity is high.16,17 Until now, the management strategy has been to accept significantly abnormal hemodynamics, often for many years, delaying the need for additional surgery as long as possible. However, the overall goal for patients like this has changed from the early days of intervention for children with tetralogy from survival alone to normalization of anatomy to the greatest extent possible with optimal preservation of cardiac function. When RV outflow tract stenosis develops after conduit insertion, what is the right time to intervene to reduce RV pressure when the objective is optimizing RV function? Does a decrease in pressure, especially when accompanied by an increase in RV volume overload, represent any net improvement in terms of maximizing RV performance? What are the sequelae, beyond the immediate risk of procedural mortality and morbidity, for repeated RV outflow tract stent placement with associated radiation exposure? Should magnetic resonance imaging rather than angiography be used as the imaging modality to address this risk? What are the functional sequelae of repeated surgical conduit valve replacement? If trading pressure normalization for a degree of volume overload is the right approach, then serial stenting to keep RV systolic pressure as low as possible should be the right course. In that setting, what are the potential late problems associated with stent fracture? If volume overload secondary to pulmonary insufficiency is the major culprit in the development of RV dysfunction, then early valve replacement should be the strategy. These are just a few of the questions raised by confirmation of the utility of this new procedure. Further advances like percutaneous pulmonary valve replacement and the development of tissue-engineered pulmonary valves seeded with a patient’s own cells make certainty of the best strategy for management even more important.18,19
Even with a standard protocol, no single center can effectively address management questions like these because patient volumes with a single diagnosis are small. Over a 15-year period, the number of patients referred for management of obstructed RV-PA conduits to the very well-regarded interventional catheterization program that reported this series averaged just over 1 per month. Only a protocol-based multicenter comparison of surgical and catheter intervention with standardized serial evaluation of hemodynamics and function has the potential to critically evaluate short-term, mid-term, and long-term results. Findings from studies like the one by Peng et al12 will ultimately allow the development of evidence-based management strategies for complex congenital heart disease. In 2001, the National Heart, Lung, and Blood Institute established the Pediatric Heart Network, a new program to provide the infrastructure for multicenter studies. With this support, a collaborative group of pediatric cardiology/congenital cardiac surgery programs has been established and is beginning to amass critical volumes of systematic data from observational studies and trials.20 The Pediatric Heart Network is not the only forum for multicenter clinical research in pediatric heart disease, but it has already demonstrated the power of combined volumes, common infrastructure, and sustained collaboration. To half a century of outstanding technical progress we will now be able to add the results of equally expert evaluation protocols, powered to answer critical questions in patient care. Management of congenital heart disease has come an enormous distance since Drs Blalock and Taussig first worked together. Cardiology and cardiac surgery teams cooperating in multicenter clinical research represent an extension of that philosophy; their findings should allow us to develop strategies that will offer our patients optimized anatomic repair, preserved cardiac function, and the best possible quality of life.
 |
Acknowledgments |
|---|
Disclosures
None.
|
Footnotes |
|---|
The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.
|
References |
|---|
 Top References |
|---|
- Blalock A, Taussig HB. Landmark article May 19, 1945: The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. By Alfred Blalock and Helen B. Taussig. JAMA. 1984; 251: 2123–2128.[CrossRef][Medline]
[Order article via Infotrieve]
- Lillehei CW, Cohen M, Warden HE, Read, RC, Aust JB, Dewall RA, Varco RL. Direct vision intracardiac surgical correction of the tetralogy of Fallot, pentalogy of Fallot, and pulmonary atresia defects; report of first ten cases. Ann Surg. 1955; 142: 418–442.[Medline]
[Order article via Infotrieve]
- Rastelli GC, Ongley PA, Davis GD, Kirklin JW. Surgical repair for pulmonary valve atresia with coronary-pulmonary artery fistula: report of a case. Mayo Clin Proc. 1965; 40: 521–527.[Medline]
[Order article via Infotrieve]
- Jonas RA, Freed MD, Mayer JE Jr, Castaneda AR. Long-term follow-up of patients with synthetic right heart conduits. Circulation. 1985; 72 (pt 2): 77–83.
- Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot in the neonate: results in the modern era. Ann Surg. 2000; 232: 508–514.[CrossRef][Medline]
[Order article via Infotrieve]
- Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, McGoon DC, Kirklin JW, Danielson GK. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993; 329: 593–599.
[Abstract/Free Full Text] - Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000; 356: 975–981.[CrossRef][Medline]
[Order article via Infotrieve]
- Webb GD, Harrison DA, Connelly MS. Challenges posed by the adult patient with congenital heart disease. Adv Intern Med. 1996; 41: 437–495.[Medline]
[Order article via Infotrieve]
- Rome JJ, Kreutzer J. Pediatric interventional catheterization: reasonable expectations and outcomes. Pediatr Clin North Am. 2004; 51: 1589–1610, viii.
- Bove EL. Facts and fantasies of congenital heart surgery: thoughts on advances in heart surgery and those who make them. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2003; 6: 184–189.[CrossRef][Medline]
[Order article via Infotrieve]
- Gidding SS, Benson DW, Clark EB, Rocchini AP. Pediatric cardiology research in 1990: a review of abstracts submitted to the Society for Pediatric Research, American Academy of Pediatrics, and American Heart Association Scientific Sessions. Pediatr Res. 1992; 32: 10–16.[Medline]
[Order article via Infotrieve]
- Peng LF, McElhinney DB, Nugent AW, Powell AJ, Marshall AC, Bacha EA, Lock JE. Endovascular stenting of obstructed right ventricle–to–pulmonary artery conduits: a 15-year experience. Circulation. 2006; 113: 2598–2605.
[Abstract/Free Full Text] - Powell AJ, Lock JE, Keane JF, Perry SB. Prolongation of RV-PA conduit life span by percutaneous stent implantation. Intermediate-term results. Circulation. 1995; 92: 3282–3288.
[Abstract/Free Full Text] - Ovaert C, Calderone CA, McCrindle BW, Nykanen D, Freedom RM, Coles JG, Williams WG, Benson LN. Endovascular stent implantation for the management of postoperative right ventricular outflow tract obstruction: clinical efficacy. J Thorac Cardiovasc Surg. 1999; 118: 886–893.
[Abstract/Free Full Text] - Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Turrentine MW. Right ventricular outflow tract reconstruction with an allograft conduit in non-ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg. 2005; 80: 655–664.
[Abstract/Free Full Text] - Mohammadi S, Belli E, Martinovic I, Houyel L, Capderou A, Petit J, Planche C, Serraf A. Surgery for right ventricle to pulmonary artery conduit obstruction: risk factors for further reoperation. Eur J Cardiothorac Surg. 2005; 28: 217–222.
[Abstract/Free Full Text] - Dearani JA, Danielson GK, Puga FJ, Schaff HV, Warnes CW, Driscoll DJ, Schleck CD, Ilstrup DM. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg. 2003; 75: 399–411.
[Abstract/Free Full Text] - Mol A, Driessen NJ, Rutten MC, Hoerstrup SP, Baaijens FP. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng. 2005; 33: 1778–1788.[CrossRef][Medline]
[Order article via Infotrieve]
- Coats L, Tsang V, Khamadkone S, van Doorn C, Cullen S, Deanfield J, de Leval MR, Bonhoeffer P. The potential impact of percutaneous pulmonary valve stent implantation on right ventricular outflow tract re-intervention. Eur J Cardiothorac Surg. 2005; 27: 536–543.
[Abstract/Free Full Text] - Mahony L, Sleeper LA, Anderson PA, Gersony WM, McCrindle BW, Minich LL, Newburger JW, Saul JP, Vetter VL, Pearson GD; Pediatric Heart Network Investigators. The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease. Pediatr Cardiol. 2006; 27: 191–198.[CrossRef][Medline]
[Order article via Infotrieve]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||